These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 29795059)

  • 1. Prevention of recurrent venous thrombosis and post-thrombotic syndrome.
    Belcaro G; Dugall M; Hu S; Feragalli B; Cotellese R; Ledda A; Corsi M; Ricci A; Ippolito E; Errichi BM; Cornelli U; Cesarone MR; Hosoi M
    Minerva Cardioangiol; 2018 Jun; 66(3):238-245. PubMed ID: 29795059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent retinal vein thrombosis: prevention with Aspirin, Pycnogenol®, ticlopidine, or sulodexide.
    Belcaro G; Dugall M; Bradford HD; Cesarone MR; Feragalli B; Gizzi C; Cotellese R; Hu S; Rodriguez P; Hosoi M
    Minerva Cardioangiol; 2019 Apr; 67(2):109-114. PubMed ID: 30964246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of sulodexide in the prevention of postthrombotic syndrome.
    Luzzi R; Belcaro G; Dugall M; Hu S; Arpaia G; Ledda A; Ippolito E; Corsi M; Ricci A; Cotellese R; Agus G; Errichi BM; Cornelli U; Cesarone MR; Hosoi M
    Clin Appl Thromb Hemost; 2014 Sep; 20(6):594-9. PubMed ID: 24781035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-haul flights, edema, and thrombotic events: prevention with stockings and Pycnogenol® supplementation (LONFLIT Registry Study).
    Belcaro G; Cornelli U; Dugall M; Hosoi M; Cotellese R; Feragalli B
    Minerva Cardioangiol; 2018 Apr; 66(2):152-159. PubMed ID: 29512362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrence of retinal vein thrombosis with Pycnogenol® or Aspirin® supplementation: a registry study.
    Rodriguez P; Belcaro G; Dugall M; Hu S; Luzzi R; Ledda A; Ippolito E; Corsi M; Ricci A; Feragalli B; Cornelli U; Gizzi C; Hosoi M
    Panminerva Med; 2015 Sep; 57(3):121-5. PubMed ID: 25971329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of post thrombotic syndrome with Pycnogenol® in a twelve month study.
    Errichi BM; Belcaro G; Hosoi M; Cesarone MR; Dugall M; Feragalli B; Bavera P; Hosoi M; Zulli C; Corsi M; Ledda A; Luzzi R; Ricci A
    Panminerva Med; 2011 Sep; 53(3 Suppl 1):21-7. PubMed ID: 22108473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of recurrent deep venous thrombosis with sulodexide: the SanVal registry.
    Errichi BM; Cesarone MR; Belcaro G; Marinucci R; Ricci A; Ippolito A; Brandolini R; Vinciguerra G; Dugall M; Felicita A; Pellegrini L; Gizzi G; Ruffini M; Acerbi G; Bavera P; Renzo AD; Corsi M; Scoccianti M; Hosoi M; Lania M
    Angiology; 2004; 55(3):243-9. PubMed ID: 15156256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the anticoagulant therapy in the incidence of post-thrombotic syndrome and recurrent thromboembolism: Comparative study of enoxaparin versus coumarin.
    González-Fajardo JA; Martin-Pedrosa M; Castrodeza J; Tamames S; Vaquero-Puerta C
    J Vasc Surg; 2008 Oct; 48(4):953-9. PubMed ID: 18639417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk and protective factors for post-thrombotic syndrome after deep venous thrombosis.
    Cucuruz B; Kopp R; Pfister K; Noppeney J; Tripal K; Korff T; Zeman F; Koller M; Noppeney T
    J Vasc Surg Venous Lymphat Disord; 2020 May; 8(3):390-395. PubMed ID: 31843481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low incidence of post-thrombotic syndrome in patients treated with new oral anticoagulants and percutaneous endovenous intervention for lower extremity deep venous thrombosis.
    Sharifi M; Freeman W; Bay C; Sharifi M; Schwartz F
    Vasc Med; 2015 Apr; 20(2):112-6. PubMed ID: 25832599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous pharmacomechanical thrombectomy offers lower risk of post-thrombotic syndrome than catheter-directed thrombolysis in patients with acute deep vein thrombosis of the lower limb.
    Huang CY; Hsu HL; Kuo TT; Lee CY; Hsu CP
    Ann Vasc Surg; 2015 Jul; 29(5):995-1002. PubMed ID: 25765634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-thrombotic syndrome in patients treated with rivaroxaban or enoxaparin/vitamin K antagonists for acute deep-vein thrombosis. A post-hoc analysis.
    Cheung YW; Middeldorp S; Prins MH; Pap AF; Lensing AW; Ten Cate-Hoek AJ; Villalta S; Milan M; Beyer-Westendorf J; Verhamme P; Bauersachs RM; Prandoni P;
    Thromb Haemost; 2016 Sep; 116(4):733-8. PubMed ID: 27583311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of venous thrombus location and extent on the development of post-thrombotic signs and symptoms.
    Labropoulos N; Waggoner T; Sammis W; Samali S; Pappas PJ
    J Vasc Surg; 2008 Aug; 48(2):407-12. PubMed ID: 18515036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of thrombolysis using tissue plasminogen activator in lower extremity deep venous thrombosis with concomitant femoral-popliteal venous segment involvement.
    Lin M; Hsieh JCF; Hanif M; McDaniel A; Chew DK
    J Vasc Surg Venous Lymphat Disord; 2017 Sep; 5(5):613-620. PubMed ID: 28818211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of mesoglycan in patients with previous deep venous thrombosis and chronic venous insufficiency.
    Andreozzi GM
    Minerva Cardioangiol; 2007 Dec; 55(6):741-53. PubMed ID: 18091643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of venous thrombosis and thrombophlebitis in long-haul flights with pycnogenol.
    Belcaro G; Cesarone MR; Rohdewald P; Ricci A; Ippolito E; Dugall M; Griffin M; Ruffini I; Acerbi G; Vinciguerra MG; Bavera P; Di Renzo A; Errichi BM; Cerritelli F
    Clin Appl Thromb Hemost; 2004 Oct; 10(4):373-7. PubMed ID: 15497024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and severity of postthrombotic syndrome after iliofemoral thrombosis - results of the Iliaca-PTS - Registry.
    Nawasrah J; Zydek B; Lucks J; Renczes J; Haberichter B; Balaban Ü; Schellong S; Lindhoff-Last E
    Vasa; 2021 Jan; 50(1):30-37. PubMed ID: 33393383
    [No Abstract]   [Full Text] [Related]  

  • 18. Risk Factors for Post-Thrombotic Syndrome in Patients With a First Proximal Deep Venous Thrombosis Treated With Direct Oral Anticoagulants.
    Spiezia L; Campello E; Simion C; Poretto A; Dalla Valle F; Simioni P
    Angiology; 2022 Aug; 73(7):649-654. PubMed ID: 34989625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A feasibility study of the safety and efficacy of a combined clopidogrel and aspirin regimen following off-pump coronary artery bypass grafting.
    Shennib H; Endo M; Benhameid O
    Heart Surg Forum; 2003; 6(5):288-91. PubMed ID: 14721795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compression stockings to prevent post-thrombotic syndrome: a randomised placebo-controlled trial.
    Kahn SR; Shapiro S; Wells PS; Rodger MA; Kovacs MJ; Anderson DR; Tagalakis V; Houweling AH; Ducruet T; Holcroft C; Johri M; Solymoss S; Miron MJ; Yeo E; Smith R; Schulman S; Kassis J; Kearon C; Chagnon I; Wong T; Demers C; Hanmiah R; Kaatz S; Selby R; Rathbun S; Desmarais S; Opatrny L; Ortel TL; Ginsberg JS;
    Lancet; 2014 Mar; 383(9920):880-8. PubMed ID: 24315521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.